Antibody-dependent CD56+ T cell responses are functionally impaired in long-term HIV-1 infection
Open Access
- 4 November 2016
- journal article
- research article
- Published by Springer Nature in Retrovirology
- Vol. 13 (1) , 1-17
Abstract
Antibody-dependent cellular cytotoxicity (ADCC), which mainly mediated by natural killer (NK) cells, may play a critical role in slowing human immunodeficiency virus type-1 (HIV-1) disease progression and protecting from HIV-1 infection. Besides classic NK cells, CD56+ T cells also have some NK cell-like properties, such as the large granular lymphocyte morphology and the capacity to destroy NK-sensitive target cells. However, little is known about the potentials of antibody-dependent CD56+ T cell responses and the association between antibody-dependent CD56+ T cell responses and HIV-1 disease progression. In the present study, we showed evidences that, in addition to NK cells, CD56+ T cells could generate degranulation upon CD16 cross-linking. Ex vivo study showed that FcγRIII (CD16)-mediated CD56+ T cell responses were distinctly induced by IgG antibody-bound P815 cells. Comparatively, CD56− T cells and invariant NKT (CD3+ 6B11+) failed to induce antibody-dependent activation. Antibody-dependent CD56+ T cell responses were mainly ascribed to CD4/CD8 double negative subset and were functionally impaired in long-term HIV-1-infected former plasma donors, regardless of hepatitis C virus (HCV) coinfection status. Also, CD56+ T cell-mediated HIV-1-specific antibody-dependent responses were declined in men who have sex with men with HIV-1 infection over 3 years. Finally, we showed that matrix metalloprotease (MMP) inhibitor GM6001 could partially restored antibody-dependent CD56+ T cell responses of chronic HIV-1-infected subjects. Our results suggested that CD56+ T cells could mediate ADCC responses and the responses were impaired in chronic HIV-1 infection.Keywords
Funding Information
- National Natural Science Foundation of China (81271826)
- National Science and Technology Major Project for Infectious Diseases (2014ZX10001001-002-004)
- State Key Laboratory of Infectious Disease Prevention and Control (2015SKLID506)
This publication has 44 references indexed in Scilit:
- Activation of NK cells by HIV-specific ADCC antibodiesHuman Vaccines & Immunotherapeutics, 2013
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy TrialNew England Journal of Medicine, 2012
- Novel Antibody Response May Explain HIV Vaccine SuccessScience, 2011
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in ThailandNew England Journal of Medicine, 2009
- Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllersAIDS, 2009
- Vaccine-Elicited Antibodies Mediate Antibody-Dependent Cellular Cytotoxicity Correlated with Significantly Reduced Acute Viremia in Rhesus Macaques Challenged with SIVmac251The Journal of Immunology, 2005
- Functional CD32 Molecules on Human NK CellsLeukemia & Lymphoma, 1999
- HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progressionThe Journal of Immunology, 1996
- Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes.The Journal of Immunology, 1988
- Different effector cell types in antibody-dependent cell-mediated cytotoxicityNature, 1975